These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 36526441)

  • 1. Increased visinin-like protein-1, YKL-40, lipocalin-2, and IL-23 levels in patients with migraine.
    Dündar A; Cafer V; Aslanhan H; Özdemir HH; Yilmaz A; Çevik MU
    Neurol Res; 2023 Feb; 45(2):97-102. PubMed ID: 36526441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid VILIP-1 and YKL-40, candidate biomarkers to diagnose, predict and monitor Alzheimer's disease in a memory clinic cohort.
    Kester MI; Teunissen CE; Sutphen C; Herries EM; Ladenson JH; Xiong C; Scheltens P; van der Flier WM; Morris JC; Holtzman DM; Fagan AM
    Alzheimers Res Ther; 2015 Sep; 7(1):59. PubMed ID: 26383836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal fluid phosphorylated tau, visinin-like protein-1, and chitinase-3-like protein 1 in mild cognitive impairment and Alzheimer's disease.
    Zhang H; Ng KP; Therriault J; Kang MS; Pascoal TA; Rosa-Neto P; Gauthier S;
    Transl Neurodegener; 2018; 7():23. PubMed ID: 30311914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging cerebrospinal fluid biomarkers in autosomal dominant Alzheimer's disease.
    Schindler SE; Li Y; Todd KW; Herries EM; Henson RL; Gray JD; Wang G; Graham DL; Shaw LM; Trojanowski JQ; Hassenstab JJ; Benzinger TLS; Cruchaga C; Jucker M; Levin J; Chhatwal JP; Noble JM; Ringman JM; Graff-Radford NR; Holtzman DM; Ladenson JH; Morris JC; Bateman RJ; Xiong C; Fagan AM;
    Alzheimers Dement; 2019 May; 15(5):655-665. PubMed ID: 30846386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective Quantification of CSF Biomarkers in Antibody-Mediated Encephalitis.
    Day GS; Yarbrough MY; Körtvelyessy P; Prüss H; Bucelli RC; Fritzler MJ; Mason W; Tang-Wai DF; Steriade C; Hébert J; Henson RL; Herries EM; Ladenson JH; Lopez-Chiriboga AS; Graff-Radford NR; Morris JC; Fagan A
    Neurology; 2021 May; 96(20):e2546-e2557. PubMed ID: 33795390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Relationship between Markers of Inflammation and Degeneration in the Central Nervous System and the Blood-Brain Barrier Impairment in Alzheimer's Disease.
    Muszyński P; Kulczyńska-Przybik A; Borawska R; Litman-Zawadzka A; Słowik A; Klimkowicz-Mrowiec A; Pera J; Dziedzic T; Mroczko B
    J Alzheimers Dis; 2017; 59(3):903-912. PubMed ID: 28697565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive value of serum visinin-like protein-1 for early neurologic deterioration and three-month clinical outcome in acute primary basal ganglia hemorrhage: A prospective and observational study.
    Yan XJ; Li YB; Liu W; Dai WM; Wang CL
    Clin Chim Acta; 2022 Jun; 531():62-67. PubMed ID: 35292254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive Value of Cerebrospinal Fluid Visinin-Like Protein-1 Levels for Alzheimer's Disease Early Detection and Differential Diagnosis in Patients with Mild Cognitive Impairment.
    Babić Leko M; Borovečki F; Dejanović N; Hof PR; Šimić G
    J Alzheimers Dis; 2016; 50(3):765-78. PubMed ID: 26836160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CSF levels of the neuronal injury biomarker visinin-like protein-1 in Alzheimer's disease and dementia with Lewy bodies.
    Luo X; Hou L; Shi H; Zhong X; Zhang Y; Zheng D; Tan Y; Hu G; Mu N; Chan J; Chen X; Fang Y; Wu F; He H; Ning Y
    J Neurochem; 2013 Dec; 127(5):681-90. PubMed ID: 23800322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of serum visinin like protein-1 and its potential for the diagnosis of brain injury due to the stroke: a pilot study.
    Stejskal D; Sporova L; Svestak M; Karpisek M
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2011 Sep; 155(3):263-8. PubMed ID: 22286812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Visinin-Like Protein-1 in the Pathophysiology of Alzheimer's Disease.
    Groblewska M; Muszyński P; Wojtulewska-Supron A; Kulczyńska-Przybik A; Mroczko B
    J Alzheimers Dis; 2015; 47(1):17-32. PubMed ID: 26402751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal Cerebrospinal Fluid Biomarker Changes in Preclinical Alzheimer Disease During Middle Age.
    Sutphen CL; Jasielec MS; Shah AR; Macy EM; Xiong C; Vlassenko AG; Benzinger TL; Stoops EE; Vanderstichele HM; Brix B; Darby HD; Vandijck ML; Ladenson JH; Morris JC; Holtzman DM; Fagan AM
    JAMA Neurol; 2015 Sep; 72(9):1029-42. PubMed ID: 26147946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of serum vaspin, visfatin, chemerin and IL-18 levels in migraine patients.
    Dönder A; Cafer V; Yilmaz A; Aslanhan H; Arikanoğlu A
    Arq Neuropsiquiatr; 2021 Sep; 79(9):789-794. PubMed ID: 34669816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum visinin-like protein-1 in concussed professional ice hockey players.
    Shahim P; Mattsson N; Macy EM; Crimmins DL; Ladenson JH; Zetterberg H; Blennow K; Tegner Y
    Brain Inj; 2015; 29(7-8):872-6. PubMed ID: 25955117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visinin-like protein 1 levels in blood and CSF as emerging markers for Alzheimer's and other neurodegenerative diseases.
    Halbgebauer S; Steinacker P; Riedel D; Oeckl P; Anderl-Straub S; Lombardi J; von Arnim CAF; Nagl M; Giese A; Ludolph AC; Otto M
    Alzheimers Res Ther; 2022 Nov; 14(1):175. PubMed ID: 36419075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-6 and YKL-40 predicted recurrent stroke after ischemic stroke or TIA: analysis of 6 inflammation biomarkers in a prospective cohort study.
    Li J; Lin J; Pan Y; Wang M; Meng X; Li H; Wang Y; Zhao X; Qin H; Liu L; Wang Y;
    J Neuroinflammation; 2022 Jun; 19(1):131. PubMed ID: 35761288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chitinase-3-like Protein 1 (YKL-40): A New Biomarker of Inflammation in Pyoderma Gangrenosum.
    Jankowska-Konsur A; Łyko M; Rubas K; Nowicka-Suszko D; Maj J; Szepietowski JC
    Acta Derm Venereol; 2022 Feb; 102():adv00646. PubMed ID: 34935995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study of the longitudinal changes in multiple cerebrospinal fluid and volumetric magnetic resonance imaging biomarkers on converter and non-converter Alzheimer's disease subjects with consideration for their amyloid beta status.
    Morar U; Izquierdo W; Martin H; Forouzannezhad P; Zarafshan E; Unger E; Bursac Z; Cabrerizo M; Barreto A; Vaillancourt DE; DeKosky ST; Loewenstein D; Duara R; Adjouadi M
    Alzheimers Dement (Amst); 2022; 14(1):e12258. PubMed ID: 35229014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum YKL-40 and IL-6 levels correlate with ultrasound findings of articular and periarticular involvement in patients with systemic sclerosis.
    Karalilova R; Kazakova M; Sapundzhieva T; Dichev V; Batalov Z; Sarafian V; Batalov A
    Rheumatol Int; 2019 Nov; 39(11):1841-1848. PubMed ID: 31375891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of YKL-40 acute-phase protein and interleukin-6 levels in periodontal disease.
    Keles ZP; Keles GC; Avci B; Cetinkaya BO; Emingil G
    J Periodontol; 2014 Sep; 85(9):1240-6. PubMed ID: 24635545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.